GEN on VetDC: 'Firm Finds New Uses for Drugs, Diagnostics, and Devices in Companion Animals'

Quoting from the Biobusiness Profile in Genetic Engineering & Biotechnology News by Carol Potera:

"Companies spend billions of dollars annually on the development of human drugs, devices, and diagnostics. Yet many promising products fail to reach the marketplace and their value is never realized. VetDC was started in Fort Collins, CO, last year to repurpose discarded and shelved technologies for veterinary use. The company in-licenses emerging, underexploited technologies from human biotechnology companies, then develops and commercializes them for dogs, cats, and other companion animals."

Link to genengnews.com

VetDC is a portfolio company of CID4. Link to learn more.

LifeScience Aurora: 'All CID4 portfolio companies presenting at upcoming RMLIPC in Denver'

Quoting from LifeScience Aurora:

"The Colorado Institute for Drug, Device and Diagnostic Development (CID4) will have all four of its portfolio companies — Sophono, PeptiVir, VetDC and Flashback Technologies — presenting and participating in discussions at the 2011 Rocky Mountain Life Science Investor and Partnering Conference Sept. 21-23 in Denver.

The four CID4 companies were announced in mid-August as part of 30 from the across the country that were hand-selected by a national committee of life science investors and business development executives for the three-day RMSLIPC conference at the Brown Palace Hotel, which draws venture capital funds, corporate venture funds and business development leaders from the largest global biopharmaceutical and medical device companies."

Link to the article

Feature: 'Venture capital drought affecting Colorado's crop of medical inventions'

Quoting from the Aurora Sentinel:

"Kevin Smith, who runs CID4, said the organization looks similar to a grant-writing agency that might fund research or some early-stage investment in a bioscience company. But that’s not really their goal, he said.

'Our mission is not just to give the money to a researcher and hope he or she comes up with something interesting, but to actually take an already identified or discovered technology and get it developed,' he said.

Smith said CID4 works with start-ups that are often in a phase of their development known is the industry as the 'valley of death.'"

Link to AuroraSentinel.com

CID4 Awards Funding and Management Assistance to Longmont's Flashback Technologies - "Advanced Patient Monitoring To Predict Patient Outcome"

Quoting from this morning's news release: "The Colorado Institute for Drug, Device and Diagnostic Development (CID4has selected Longmont, Colorado-based Flashback Technologies, Inc. to receive funding and management assistance. Flashback is advancing development of their proprietary learning framework for the real-time analysis of physiological data.

Hemorrhage is the number one cause of potentially preventable death on the battlefield and in civilian trauma settings. Work under development includes a device powered by software that quickly and reliably detects and estimates blood loss volume and predicts a time to cardiovascular collapse.

Discoveries at the University of Colorado, Anschutz Medical Campus, Department of Surgery, the University of Colorado, Boulder, Department of Computer Science, and the U.S. Army Institute of Surgical Research have revealed several previously unknown hemodynamic relationships leading to a patent-pending platform technology for the real-time analysis of human vital sign data. A set of algorithms, collectively termed the Cardiovascular Reserve Monitor (CRM), is under development with funding from the U.S. Army. The CRM takes as inputs non-invasive physiological sensor data that in real-time: 1) Detects the early onset of hypovolemia (blood loss) 2) Estimates blood loss volume, and 3) Predicts a patient's individual risk for cardiovascular collapse."

Link to the Pitch Engine social media release

BCBR: "CID4 seeks bioscience project to fund"

Quoting from today's article by Beth Potter:

"AURORA - A nonprofit bioscience funding group that has given money to two Boulder County companies is looking to give a grant of up to $600,000 to a new project.

Companies should submit requests to the Colorado Institute for Drug, Device and Diagnostic Development, or CID4, which so far has committed $1.25 million to four projects. The deadline to ask for money is Friday, Aug. 5. For details on the selection process, go to http://cid4.com."

Link to the Boulder County Business Report

Deadline: CID4 Sets Aug 5 Cut-off for Inclusion in Fifth Project Funding Review

Aurora, CO July 22, 2011 – The Colorado Institute for Drug, Device and Diagnostic Development (CID4), a 501(c)(3) not-for-profit entity focused on advancing the Colorado life science ecosystem through company creation and job growth, is seeking its fifth project. A review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration.

Link to the related CID4 blog post

Link to the Pitch Engine posting

CID4 Blog: "When is a New Website Not Just A Website?"

There's a new website in town...CID4's:

"When is a new website not just your run of the mill website? Well … when that website happens to be CID4’s new website.

Launched on 1 July 2011, the new CID4.com is a virtual 'office in the cloud' that enables the management team to maximize efficiencies while catalyzing the growth of the early-stage Colorado life science community. How can a website do all that, you ask? Good question, here is a closer look at some of the new functionality."

Link to the CID4 Blog